Notify me when Iris Acquisition Holdings LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| LIMN | Liminatus Pharma, Inc. | Common Stock | 26% | 6,900,000 | Iris Acquisition Holdings LLC | 30 Apr 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|